Speciality: Hematology
Language
: Polski
Duration
: 00:15:37
Date: September 25, 2015
Find more about clinical benefits for high-risk patients with relapsed or refractory CLL treated with Imbruvica®.
See moreOur website is using cookie data storing mechanisms according to rules described in Terms of cookie files policy. To read more about the types of cookie files used by our website see Annex to the above document. If you agree to cookie policy of our website you are welcome to more...
Close
Speciality: Hematology
Language
: Polski
Duration
: 00:15:37
Date: September 25, 2015
Find more about clinical benefits for high-risk patients with relapsed or refractory CLL treated with Imbruvica®.
See more